Related Experiment Videos
Macrolides induced suppression of virulence factors produced by Staphylococcus aureus
N A Moneib1, A M Shibl, M A el-Said
1Division of Microbiology, King Saud University, Riyadh, Saudi Arabi.
Abstract:
The effect of sub-MICs of azithromycin, clarithromycin and roxithromycin, as compared to erythromycin, on the production of coagulase, beta-hemolysin, lecithinase and deoxyribonuclease by Staphylococcus aureus was studied. All new macrolides completely inhibited coagulase and beta-hemolysin production and partially inhibited lecithinase and deoxyribonuclease. Such inhibition is not related either to growth inhibition or to inhibition of enzyme activity. Erythromycin, on the other hand, had no effect on coagulase or beta-hemolysin production but slightly suppressed the production of lecithinase and deoxyribonuclease. This inhibitory effect might have clinical significance if it was found to occur in vivo.
Insights
Newer macrolides like azithromycin effectively inhibit Staphylococcus aureus virulence factors, including coagulase and beta-hemolysin. This occurs independently of growth inhibition, suggesting potential clinical applications for these antibiotics.
Area of Science:
- Microbiology
- Pharmacology
- Infectious Diseases
Background:
- Staphylococcus aureus is an opportunistic pathogen that produces various toxins and enzymes contributing to its virulence.
- The clinical efficacy of antibiotics can be influenced by their impact on bacterial virulence factor production, not just growth inhibition.
Purpose of the Study:
- To investigate the effect of sub-inhibitory concentrations (sub-MICs) of newer macrolides (azithromycin, clarithromycin, roxithromycin) and erythromycin on the production of key Staphylococcus aureus virulence factors.
- To determine if observed effects are linked to growth inhibition or direct enzyme activity inhibition.
Main Methods:
- Culturing Staphylococcus aureus in the presence of sub-MICs of azithromycin, clarithromycin, roxithromycin, and erythromycin.
- Quantifying the production of coagulase, beta-hemolysin, lecithinase, and deoxyribonuclease.
- Assessing bacterial growth and direct enzyme activity to differentiate effects.
Main Results:
- Azithromycin, clarithromycin, and roxithromycin completely inhibited coagulase and beta-hemolysin production.
- These new macrolides partially inhibited lecithinase and deoxyribonuclease production at sub-MICs.
- Erythromycin showed minimal suppression of lecithinase and deoxyribonuclease, with no effect on coagulase or beta-hemolysin.
- The observed inhibition of virulence factors by new macrolides was independent of bacterial growth inhibition or direct enzyme activity suppression.
Conclusions:
- Newer macrolides possess potent anti-virulence properties against Staphylococcus aureus, distinct from their bactericidal effects.
- The inhibition of coagulase and beta-hemolysin by azithromycin, clarithromycin, and roxithromycin suggests a novel mechanism of action.
- These findings warrant further in vivo investigation to explore the clinical significance of macrolide-mediated virulence factor suppression in treating Staphylococcus aureus infections.